ying-hong feng
Uniformed Services University of the Health Sciences
Bethesda, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Uniformed Services University of the Health Sciences
Bethesda, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Semmelweis University
Budapest, Hungary
Associate Editor
Translational Pharmacology
CBIOS, Universidade LusĂłfona Research Center for Biosciences & Health Technologies
Lisbon, Portugal
Associate Editor
Pharmacology of Anti-Cancer Drugs
Federal University of Santa Catarina
Florianopolis, Brazil
Associate Editor
Cardiovascular and Smooth Muscle Pharmacology
Federal University of Rio de Janeiro
Rio de Janeiro, Brazil
Associate Editor
Inflammation Pharmacology
Spanish National Research Council (CSIC)
Madrid, Spain
Associate Editor
Gastrointestinal and Hepatic Pharmacology
University of Barcelona
Barcelona, Spain
Associate Editor
Neuropharmacology
Catholic University of the Sacred Heart
Milano, Italy
Associate Editor
Inflammation Pharmacology
University of Studies G. d'Annunzio Chieti and Pescara
Chieti, Italy
Associate Editor
Ethnopharmacology
University of Ferrara
Ferrara, Italy
Associate Editor
Neuropharmacology
University of Geneva
Geneva, Switzerland
Associate Editor
Ethnopharmacology
Miguel Hernández University of Elche
Elche, Spain
Associate Editor
Pharmacology of Ion Channels and Channelopathies
New York Medical College
Valhalla, United States
Associate Editor
Inflammation Pharmacology
Langone Medical Center, New York University
New York City, United States
Associate Editor
Pharmacology of Ion Channels and Channelopathies
University of Freiburg
Freiburg, Germany
Associate Editor
Ethnopharmacology
University of Bologna
Bologna, Italy
Associate Editor
Pharmacology of Anti-Cancer Drugs